GPN Vaccines
Chemicals & Related Products · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 4435, Manuka, Australian Capital ...Phone Number
+61 883134671Website
www.gpnvaccines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About GPN Vaccines
GPN Vaccines is a public (unlisted) biotechnology company developing a vaccine against Streptococcus pneumoniae, which is responsible for causing life-threatening pneumonia, bacteraemia and meningitis, as well as otitis media (middle ear infections).Explore more
GPN Vaccines Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GPN Vaccines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at GPN Vaccines
Check if GPN Vaccines has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on GPN Vaccines recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once GPN Vaccines has new funding data
Check out if GPN Vaccines is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if GPN Vaccines had a recent Job posting/layoffs
Product Launch: Get notified when GPN Vaccines launches new products
GPN Vaccines, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at GPN Vaccines
Find 2 more new buyers
Compare Similar Companies to GPN Vaccines
Compare insights from companies similar to GPN Vaccines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GPN Vaccines is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GPN Vaccines is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GPN Vaccines.
GPN Vaccines financials insights
Gather financial insights about GPN Vaccines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$12M
2026
Stock/Share Issuance
$3.5M
GPN Vaccines Tech Stack
A closer look at the technologies used by GPN Vaccines
See more technologies
GPN Vaccines News & Media
First Participant Dosed in Phase 1 Clinical Trial of Gamma-PN in Older Adults
ADELAIDE, SOUTH AUSTRALIA, AUSTRALIA, September 12, 2024 /EINPresswire.com/ -- GPN Vaccines Ltd is pleased to announce that the first participant has been dosed in its Phase 1 clinical trial of Gamma-PN vaccine in older adults. The Phase 1 clinical …GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN
ADELAIDE, Australia, Jan. 4, 2024 /PRNewswire/ -- GPN Vaccines Ltd, a clinical-stage biotechnology company developing a Streptococcus pneumoniae vaccine to prevent life-threatening pneumonia, bacteraemia and meningitis, is pleased to announce positive safety and immunogenicity data from its Phase 1 trial of Gamma-PN, a non-adjuvanted whole cell-pneumococcal vaccine being investigated in adults aged 50 to 69 years. In this double-blind, randomised study with placebo and active controls, 120 partiBioCina Expands Partnership with GPN Vaccines
ADELAIDE, South Australia, Nov. 6, 2023 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics contract development and manufacturing organization (CDMO), announced the expansion of their partnership with GPN Vaccines Ltd. GPN Vaccines is a biotechnology company developing a...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GPN Vaccines
Sign Up For FreeTo access detailed company insights
GPN Vaccines is a public (unlisted) biotechnology company developing a vaccine against Streptococcus pneumoniae, which is responsible for causing life-threatening pneumonia, bacteraemia and meningitis, as well as otitis media (middle ear infections).... Read More
